National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.
Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.
Scotland is first part of the UK to make a drug routinely available on the NHS that can extend the lives of women with an aggressive form of breast cancer.
A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.
Three key waiting time targets for cancer patients in Northern Ireland have been missed, according to the latest figures.